CN108938858A - A kind of activating microcirculation and removing stasis medicinal plaster - Google Patents

A kind of activating microcirculation and removing stasis medicinal plaster Download PDF

Info

Publication number
CN108938858A
CN108938858A CN201811010186.3A CN201811010186A CN108938858A CN 108938858 A CN108938858 A CN 108938858A CN 201811010186 A CN201811010186 A CN 201811010186A CN 108938858 A CN108938858 A CN 108938858A
Authority
CN
China
Prior art keywords
parts
pollen
removing stasis
oils
stasis medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201811010186.3A
Other languages
Chinese (zh)
Inventor
李靖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dongguan Dazzling Mo Biotechnology Co Ltd
Original Assignee
Dongguan Dazzling Mo Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dongguan Dazzling Mo Biotechnology Co Ltd filed Critical Dongguan Dazzling Mo Biotechnology Co Ltd
Priority to CN201811010186.3A priority Critical patent/CN108938858A/en
Publication of CN108938858A publication Critical patent/CN108938858A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/324Boswellia, e.g. frankincense
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/533Leonurus (motherwort)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/79Schisandraceae (Schisandra family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/37Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of activating microcirculation and removing stasis medicinal plaster, including following raw materials: Radix Notoginseng, rhizome of chuanxiong, safflower, Radix Salviae Miltiorrhizae, olibanum, Radix Angelicae Sinensis, motherwort, Pollen Typhae, borneol, litsea citrate oil, Fructus Forsythiae oil, Rhizoma Acori Graminei oil, pollen extract, Sodium Aescinate, albiflorin, gypsum.The present invention is according to traditional Chinese medical theory formula, each drug coordinated, strengthens the body resistance to consolidate the constitution, Eradicates trembles with fear dehumidifying, warming and activating meridian, activating microcirculation and removing stasis medicinal and analgesic, is applied with use, safe ready has no toxic side effect.Compared with prior art, the effect of activating microcirculation and removing stasis medicinal plaster of the invention, effective component can be rapidly permeated into and is absorbed by the skin, realization activating microcirculation and removing stasis medicinal, swelling and pain relieving;Meanwhile improvement skin environment, pore is dredged, skin barrier function is improved, repairs impaired skin, has effects that anti-oxidant, removing free radical.

Description

A kind of activating microcirculation and removing stasis medicinal plaster
Technical field
The present invention relates to a kind of activating microcirculation and removing stasis medicinal plaster.
Background technique
Traumatic injury refers to people because of the soft tissue injury caused by the reasons such as falling, beating, touch, crack between the teeth, with swelling, pain for main table It is existing.Chinese traditional treatment traumatic injury has thousands of years history, and ancient " traumatic injury " is referred to as the introduction of all wounds, mostly because of external force, Or it overexerts and causes in the case where itself fault.Chinese medicine hurts all muscles and bones because of caused by external force in human body Damage, extravasated blood swelling and pain, derangement of Qi and blood, blockage of main and collateral channels are impaired etc. down to internal organs, are referred to as traumatic injury.
For a long time, furuncle, traumatic injury are treated mostly based on massage, hot compress, west plaster, but there are physical therapy times Length, slow effect, patient endure the drawbacks such as pain torment to the fullest extent for a long time, and certain anti-inflammatory drugs and promoting blood circulation class drug are hormone medicine, right Body is irritant, and long-term use can generate tolerance and certain side effect.
Plaster is one of main method of external treatment with Chinese medicine, as one piece of rarity of my Chinese nation, is played always for many years Irreplaceable role.Practice was continued to use by 1,100, sufficiently proves that plaster has " easy to use, cheap, effect Rapidly, significant in efficacy " the advantages that.
Since plaster is directly applied to body surface, and the most smell of drug for making paste is denseer, interior by infiltrating through skin Transmit scriptures network, internal organs, the effects of it is wet to play regulating the qi flowing in the channels blood, degrading the channel, cold dispelling, pain of reducing swelling, therefore plaster use scope is extensive, be easy to by People receive.The present invention provides a kind of activating microcirculation and removing stasis medicinal plaster, and effective component can be rapidly permeated into and is absorbed by the skin, and realizes promoting blood circulationization The effect of stasis of blood, swelling and pain relieving;Meanwhile improving skin environment, pore is dredged, skin barrier function is improved, repairs impaired skin, tool There is the effect of anti-oxidant, removing free radical.
Summary of the invention
The purpose of the present invention is to provide a kind of activating microcirculation and removing stasis medicinal plaster.
Specific technical solution is as follows:
A kind of activating microcirculation and removing stasis medicinal plaster, including following raw materials are prepared: Radix Notoginseng, rhizome of chuanxiong, safflower, Radix Salviae Miltiorrhizae, olibanum, Radix Angelicae Sinensis, Motherwort, Pollen Typhae, borneol, gypsum.
A kind of activating microcirculation and removing stasis medicinal plaster, the raw material including following weight parts are prepared: 50~75 portions of Radix Notoginseng, 25~38 parts of rivers Vault, 15~25 parts of safflowers, 10~30 parts of Radix Salviae Miltiorrhizaes, 10~30 parts of olibanums, 10~20 parts of Radix Angelicae Sinensis, 8~16 portions of motherworts, 6~20 parts Pollen Typhae, 4~8 parts of borneols, 140~270 parts of gypsum.
A kind of activating microcirculation and removing stasis medicinal plaster, the raw material including following weight parts are prepared: 50~75 portions of Radix Notoginseng, 25~38 parts of rivers Vault, 15~25 parts of safflowers, 10~30 parts of Radix Salviae Miltiorrhizaes, 10~30 parts of olibanums, 10~20 parts of Radix Angelicae Sinensis, 8~16 portions of motherworts, 6~20 parts Pollen Typhae, 4~8 parts of borneols, 5-10 portions of litsea citrate oils, 5-10 parts of Fructus Forsythiae oils, 5-10 parts of Rhizoma Acori Graminei oils, 140~270 parts of gypsum.
A kind of activating microcirculation and removing stasis medicinal plaster, the raw material including following weight parts are prepared: 50~75 portions of Radix Notoginseng, 25~38 parts of rivers Vault, 15~25 parts of safflowers, 10~30 parts of Radix Salviae Miltiorrhizaes, 10~30 parts of olibanums, 10~20 parts of Radix Angelicae Sinensis, 8~16 portions of motherworts, 6~20 parts Pollen Typhae, 4~8 parts of borneols, 5-10 portions of litsea citrate oils, 5-10 parts of Fructus Forsythiae oils, 5-10 parts of Rhizoma Acori Graminei oils, 2-8 parts of pollen extracts, 140~270 parts of gypsum.
A kind of activating microcirculation and removing stasis medicinal plaster, the raw material including following weight parts are prepared: 50~75 portions of Radix Notoginseng, 25~38 parts of rivers Vault, 15~25 parts of safflowers, 10~30 parts of Radix Salviae Miltiorrhizaes, 10~30 parts of olibanums, 10~20 parts of Radix Angelicae Sinensis, 8~16 portions of motherworts, 6~20 parts Pollen Typhae, 4~8 parts of borneols, 5-10 portions of litsea citrate oils, 5-10 parts of Fructus Forsythiae oils, 5-10 parts of Rhizoma Acori Graminei oils, 2-8 parts of pollen extracts, 0.2-3 parts of Sodium Aescinates and/or albiflorin, 140~270 parts of gypsum.
A kind of activating microcirculation and removing stasis medicinal plaster, the raw material including following weight parts are prepared: 50~75 portions of Radix Notoginseng, 25~38 parts of rivers Vault, 15~25 parts of safflowers, 10~30 parts of Radix Salviae Miltiorrhizaes, 10~30 parts of olibanums, 10~20 parts of Radix Angelicae Sinensis, 8~16 portions of motherworts, 6~20 parts Pollen Typhae, 4~8 parts of borneols, 5-10 portions of litsea citrate oils, 5-10 parts of Fructus Forsythiae oils, 5-10 parts of Rhizoma Acori Graminei oils, 2-8 parts of pollen extracts, The mixture of 0.2-3 parts of Sodium Aescinates and albiflorin, 140~270 parts of gypsum;The Sodium Aescinate and peony lactone The mass ratio of glycosides is (1-3): (1-3).
Preferably, the pollen extract the preparation method is as follows: by 5-8g pollen carry out supercritical carbon dioxide extracting, Extracting pressure is 25-35MPa, and extraction temperature is 45-55 DEG C, and extraction time is 2-4 hours, carbon dioxide flow rate 40-50L/ H, I temperature of separating still are 40-50 DEG C, pressure 10-15MPa, and II temperature of separating still is 25-35 DEG C, pressure 5-8MPa, are collected Supercritical extract to get arrive pollen extract.
Preferably, the pollen is Schisandra chinensis pollen.
Schisandra chinensis pollen contains a variety of volatile oil, can enhance the fragrance of essential oil, and calm nerves have and calm the nerves, is anti-oxidant, disappearing Scorching, antibacterial effect.
Litsea citrate oil, Fructus Forsythiae oil, Rhizoma Acori Graminei oil have the function of good tranquilizing the mind, anti-oxidant, antiphlogistic antibacterial.
Sodium Aescinate is the soap extracted from the dry mature seed of Hippocastanaceae plant buckeye (Aesculi) Glycosides sodium salt, modern pharmacology research show it with good pharmacological activity: having very strong anti-inflammatory, anti-transudation;Subtract Formation that is light and eliminating oedema or hemotoncus;Antioxidant radical and have the function of neuroprotection.Clinically it is mainly used for treatment wound Wound or perform the operation caused by swelling, brain edema, venous return obstacle disease, while find to pulmonary heart disease, tumour, anal canal edema, A variety of diseases such as facial neuritis and I type nephrotic syndrome also have a good effect.
A kind of preparation method of activating microcirculation and removing stasis medicinal plaster, comprising the following steps:
S1 weighs raw material by weight, and Radix Notoginseng, rhizome of chuanxiong, safflower, Radix Salviae Miltiorrhizae, olibanum, Radix Angelicae Sinensis, motherwort, Pollen Typhae are crushed Obtain Chinese medicine coarse powder to 80~300 mesh, by Chinese medicine coarse powder be added to 5~10 times of Chinese medicine coarse powder weight mass fraction be 60~ In 80% ethanol water, it is stirred at reflux 1.5~4h of extraction at 70~85 DEG C, filters, reduction vaporization to relative density is 1.15~1.22, obtain paste extract;
S2 by paste extract, borneol, litsea citrate oil (if there is), Fructus Forsythiae oil (if there is), Rhizoma Acori Graminei oil (if there is), Pollen extract (if there is), Sodium Aescinate (if there is), albiflorin (if there is), gypsum are uniformly mixed, and are obtained To activating microcirculation and removing stasis medicinal plaster.
The present invention is according to traditional Chinese medical theory formula, each drug coordinated, strengthen the body resistance to consolidate the constitution, Eradicates tremble with fear dehumidifying, warming and activating meridian, The effect of activating microcirculation and removing stasis medicinal and analgesic, is applied with and uses, and safe ready has no toxic side effect.
The present invention provides a kind of activating microcirculation and removing stasis medicinal plaster, and effective component can be rapidly permeated into and is absorbed by the skin, and realizes activating microcirculation and removing stasis medicinal, The effect of swelling and pain relieving;Meanwhile improving skin environment, pore is dredged, skin barrier function is improved, impaired skin is repaired, has It is anti-oxidant, remove free radical the effect of.
On the basis of common knowledge of the art, above-mentioned each optimum condition, can be each preferably to get the present invention in any combination Embodiment.
Specific embodiment
The present invention is further illustrated below by the mode of embodiment, but does not therefore limit the present invention to the reality It applies among a range.In the following examples, the experimental methods for specific conditions are not specified, according to conventional methods and conditions, or according to quotient The selection of product specification.
Embodiment 1
A kind of activating microcirculation and removing stasis medicinal plaster, the raw material including following weight parts are prepared: 62 portions of Radix Notoginseng, 30 parts of rhizome of chuanxiongs, 18 parts Safflower, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of olibanums, 15 parts of Radix Angelicae Sinensis, 10 portions of motherworts, 8 parts of Pollen Typhaes, 5 parts of borneols, 173 parts of gypsum.
The preparation method of above-mentioned activating microcirculation and removing stasis medicinal plaster, comprising the following steps:
S1 weighs raw material by weight, and Radix Notoginseng, rhizome of chuanxiong, safflower, Radix Salviae Miltiorrhizae, olibanum, Radix Angelicae Sinensis, motherwort, Pollen Typhae are crushed Chinese medicine coarse powder is obtained to 300 mesh, it is water-soluble that Chinese medicine coarse powder is added to the ethyl alcohol that the mass fraction of 8 times of Chinese medicine coarse powder weight is 75% It in liquid, is stirred at reflux at 80 DEG C and extracts 3h, the paste extract for being 1.2 to relative density is evaporated under reduced pressure in filtering;
Paste extract, borneol, gypsum are uniformly mixed by S2, obtain activating microcirculation and removing stasis medicinal plaster.
Embodiment 2
A kind of activating microcirculation and removing stasis medicinal plaster, the raw material including following weight parts are prepared: 62 portions of Radix Notoginseng, 30 parts of rhizome of chuanxiongs, 18 parts Safflower, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of olibanums, 15 parts of Radix Angelicae Sinensis, 10 portions of motherworts, 8 parts of Pollen Typhaes, 5 parts of borneols, 8 portions of litsea citrate oils, 8 parts Fructus Forsythiae oil, 8 parts of Rhizoma Acori Graminei oils, 173 parts of gypsum.
The preparation method of above-mentioned activating microcirculation and removing stasis medicinal plaster, comprising the following steps:
S1 weighs raw material by weight, and Radix Notoginseng, rhizome of chuanxiong, safflower, Radix Salviae Miltiorrhizae, olibanum, Radix Angelicae Sinensis, motherwort, Pollen Typhae are crushed Chinese medicine coarse powder is obtained to 300 mesh, it is water-soluble that Chinese medicine coarse powder is added to the ethyl alcohol that the mass fraction of 8 times of Chinese medicine coarse powder weight is 75% It in liquid, is stirred at reflux at 80 DEG C and extracts 3h, the paste extract for being 1.2 to relative density is evaporated under reduced pressure in filtering;
Paste extract, borneol, litsea citrate oil, Fructus Forsythiae oil, Rhizoma Acori Graminei oil, gypsum are uniformly mixed by S2, are lived Blood stasis-resolving plaster.
Embodiment 3
A kind of activating microcirculation and removing stasis medicinal plaster, the raw material including following weight parts are prepared: 62 portions of Radix Notoginseng, 30 parts of rhizome of chuanxiongs, 18 parts Safflower, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of olibanums, 15 parts of Radix Angelicae Sinensis, 10 portions of motherworts, 8 parts of Pollen Typhaes, 5 parts of borneols, 8 portions of litsea citrate oils, 8 parts Fructus Forsythiae oil, 8 parts of Rhizoma Acori Graminei oils, 5 parts of Schisandra chinensis pollen extracts, 173 parts of gypsum.
The Schisandra chinensis pollen extract the preparation method is as follows: by 6g Schisandra chinensis pollen carry out supercritical carbon dioxide extraction It takes, extracting pressure 30MPa, extraction temperature is 50 DEG C, and extraction time is 3 hours, carbon dioxide flow rate 45L/h, separating still I Temperature is 45 DEG C, pressure 12MPa, and II temperature of separating still is 30 DEG C, pressure 6MPa, collects supercritical extract to get arriving Schisandra chinensis pollen extract.
The preparation method of above-mentioned activating microcirculation and removing stasis medicinal plaster, comprising the following steps:
S1 weighs raw material by weight, and Radix Notoginseng, rhizome of chuanxiong, safflower, Radix Salviae Miltiorrhizae, olibanum, Radix Angelicae Sinensis, motherwort, Pollen Typhae are crushed Chinese medicine coarse powder is obtained to 300 mesh, it is water-soluble that Chinese medicine coarse powder is added to the ethyl alcohol that the mass fraction of 8 times of Chinese medicine coarse powder weight is 75% It in liquid, is stirred at reflux at 80 DEG C and extracts 3h, the paste extract for being 1.2 to relative density is evaporated under reduced pressure in filtering;
S2 stirs paste extract, borneol, litsea citrate oil, Fructus Forsythiae oil, Rhizoma Acori Graminei oil, Schisandra chinensis pollen extract, gypsum It mixes uniformly mixed, obtains activating microcirculation and removing stasis medicinal plaster.
Embodiment 4
A kind of activating microcirculation and removing stasis medicinal plaster, the raw material including following weight parts are prepared: 62 portions of Radix Notoginseng, 30 parts of rhizome of chuanxiongs, 18 parts Safflower, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of olibanums, 15 parts of Radix Angelicae Sinensis, 10 portions of motherworts, 8 parts of Pollen Typhaes, 5 parts of borneols, 8 portions of litsea citrate oils, 8 parts Fructus Forsythiae oil, 8 parts of Rhizoma Acori Graminei oils, 5 parts of Schisandra chinensis pollen extracts, 1.5 parts of Sodium Aescinates, 173 parts of gypsum.
The Schisandra chinensis pollen extract the preparation method is as follows: by 6g Schisandra chinensis pollen carry out supercritical carbon dioxide extraction It takes, extracting pressure 30MPa, extraction temperature is 50 DEG C, and extraction time is 3 hours, carbon dioxide flow rate 45L/h, separating still I Temperature is 45 DEG C, pressure 12MPa, and II temperature of separating still is 30 DEG C, pressure 6MPa, collects supercritical extract to get arriving Schisandra chinensis pollen extract.
The preparation method of above-mentioned activating microcirculation and removing stasis medicinal plaster, comprising the following steps:
S1 weighs raw material by weight, and Radix Notoginseng, rhizome of chuanxiong, safflower, Radix Salviae Miltiorrhizae, olibanum, Radix Angelicae Sinensis, motherwort, Pollen Typhae are crushed Chinese medicine coarse powder is obtained to 300 mesh, it is water-soluble that Chinese medicine coarse powder is added to the ethyl alcohol that the mass fraction of 8 times of Chinese medicine coarse powder weight is 75% It in liquid, is stirred at reflux at 80 DEG C and extracts 3h, the paste extract for being 1.2 to relative density is evaporated under reduced pressure in filtering;
S2 is by paste extract, borneol, litsea citrate oil, Fructus Forsythiae oil, Rhizoma Acori Graminei oil, Schisandra chinensis pollen extract, seven leaf soaps Glycosides sodium, gypsum are uniformly mixed, and obtain activating microcirculation and removing stasis medicinal plaster.
Embodiment 5
A kind of activating microcirculation and removing stasis medicinal plaster, the raw material including following weight parts are prepared: 62 portions of Radix Notoginseng, 30 parts of rhizome of chuanxiongs, 18 parts Safflower, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of olibanums, 15 parts of Radix Angelicae Sinensis, 10 portions of motherworts, 8 parts of Pollen Typhaes, 5 parts of borneols, 8 portions of litsea citrate oils, 8 parts Fructus Forsythiae oil, 8 parts of Rhizoma Acori Graminei oils, 5 parts of Schisandra chinensis pollen extracts, 1.5 parts of albiflorins, 173 parts of gypsum.
The Schisandra chinensis pollen extract the preparation method is as follows: by 6g Schisandra chinensis pollen carry out supercritical carbon dioxide extraction It takes, extracting pressure 30MPa, extraction temperature is 50 DEG C, and extraction time is 3 hours, carbon dioxide flow rate 45L/h, separating still I Temperature is 45 DEG C, pressure 12MPa, and II temperature of separating still is 30 DEG C, pressure 6MPa, collects supercritical extract to get arriving Schisandra chinensis pollen extract.
The preparation method of above-mentioned activating microcirculation and removing stasis medicinal plaster, comprising the following steps:
S1 weighs raw material by weight, and Radix Notoginseng, rhizome of chuanxiong, safflower, Radix Salviae Miltiorrhizae, olibanum, Radix Angelicae Sinensis, motherwort, Pollen Typhae are crushed Chinese medicine coarse powder is obtained to 300 mesh, it is water-soluble that Chinese medicine coarse powder is added to the ethyl alcohol that the mass fraction of 8 times of Chinese medicine coarse powder weight is 75% It in liquid, is stirred at reflux at 80 DEG C and extracts 3h, the paste extract for being 1.2 to relative density is evaporated under reduced pressure in filtering;
S2 will be in paste extract, borneol, litsea citrate oil, Fructus Forsythiae oil, Rhizoma Acori Graminei oil, Schisandra chinensis pollen extract, Chinese herbaceous peony Ester glycosides, gypsum are uniformly mixed, and obtain activating microcirculation and removing stasis medicinal plaster.
Embodiment 6
A kind of activating microcirculation and removing stasis medicinal plaster, the raw material including following weight parts are prepared: 62 portions of Radix Notoginseng, 30 parts of rhizome of chuanxiongs, 18 parts Safflower, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of olibanums, 15 parts of Radix Angelicae Sinensis, 10 portions of motherworts, 8 parts of Pollen Typhaes, 5 parts of borneols, 8 portions of litsea citrate oils, 8 parts Fructus Forsythiae oil, 8 parts of Rhizoma Acori Graminei oils, 5 parts of Schisandra chinensis pollen extracts, 0.75 part of Sodium Aescinate, 0.75 part of albiflorin, 173 Part gypsum.
The Schisandra chinensis pollen extract the preparation method is as follows: by 6g Schisandra chinensis pollen carry out supercritical carbon dioxide extraction It takes, extracting pressure 30MPa, extraction temperature is 50 DEG C, and extraction time is 3 hours, carbon dioxide flow rate 45L/h, separating still I Temperature is 45 DEG C, pressure 12MPa, and II temperature of separating still is 30 DEG C, pressure 6MPa, collects supercritical extract to get arriving Schisandra chinensis pollen extract.
The preparation method of above-mentioned activating microcirculation and removing stasis medicinal plaster, comprising the following steps:
S1 weighs raw material by weight, and Radix Notoginseng, rhizome of chuanxiong, safflower, Radix Salviae Miltiorrhizae, olibanum, Radix Angelicae Sinensis, motherwort, Pollen Typhae are crushed Chinese medicine coarse powder is obtained to 300 mesh, it is water-soluble that Chinese medicine coarse powder is added to the ethyl alcohol that the mass fraction of 8 times of Chinese medicine coarse powder weight is 75% It in liquid, is stirred at reflux at 80 DEG C and extracts 3h, the paste extract for being 1.2 to relative density is evaporated under reduced pressure in filtering;
S2 is by paste extract, borneol, litsea citrate oil, Fructus Forsythiae oil, Rhizoma Acori Graminei oil, Schisandra chinensis pollen extract, seven leaf soaps Glycosides sodium, albiflorin, gypsum are uniformly mixed, and obtain activating microcirculation and removing stasis medicinal plaster.
Primary raw material used is as follows in embodiment:
Chinese medicine material Radix Notoginseng, rhizome of chuanxiong, safflower, Radix Salviae Miltiorrhizae, olibanum, Radix Angelicae Sinensis, motherwort, Pollen Typhae believe remote Chinese medicine purchased from Bozhou City Science and Technology Ltd..Borneol, CAS 507-70-0.Gypsum, 200 mesh of partial size, often rich medicine company sells Co., Ltd to Bozhou City.Five Taste pollen: the pollen of magnoliaceae schisandra Schisandra chinensis (Turcz.) Baill..Litsea citrate oil: CAS:68855-99-2, Shanghai ShuaiSun Industrial Co., Ltd., product number: SS000708.Fructus Forsythiae oil: CAS:68917-49-7, Shanghai ShuaiSun Industrial Co., Ltd., product number: SS000612.Rhizoma Acori Graminei oil: CAS:91745-11-8, the handsome limited public affairs of Son industry Department, product number: SS000589.Sodium Aescinate: CAS:20977-05-3, ShuaiSun Industrial Co., Ltd., product number: SS005987.Albiflorin: CAS:39011-90-0, ShuaiSun Industrial Co., Ltd., product number: SS005992.
The clinical observation experiment of plaster treatment soft tissue injury
Test method: every group of test group randomly selects 50 soft tissue injury patients respectively, tests 6 groups of component, every component Activating microcirculation and removing stasis medicinal plaster in other Examples 1 to 6 spreads on affected part after pico- heating and softening, and each topical application of drug of test group uses 12h, It applies 7 days altogether, clinical observation result is as shown in table 1.
1 soft tissue injury therapeutic effect table of table
It cures It is effective Effectively In vain
Embodiment 1 30 9 6 5
Embodiment 2 33 9 5 3
Embodiment 3 36 7 5 2
Embodiment 4 41 7 2 0
Embodiment 5 42 6 2 0
Embodiment 6 46 3 1 0
The test of DPPH elimination effect:
The ability for removing DPPH free radical to the activating microcirculation and removing stasis medicinal plaster of embodiment 4-6 is tested: by activating microcirculation and removing stasis medicinal plaster It in the ethanol water that the volume fraction for being added to its 8 times of weight is 95%, is uniformly mixed, is filtered, obtained with 800 mesh grenadines The filtrate arrived is sample solution;Into the quartz colorimetric utensil of 1cm be added sample solution 2.0mL and 2.0mL molar concentration be 1.0 × 104The DPPH solution of mol/L, after mixing dark place place 30 minutes, using volume fraction be 95% ethanol water as Reference solution measures the light absorption value A at 517nm;It is 95% that same method, which measures sample solution 2.0mL and 2.0mL volume fraction, Light absorption value Ao of the ethanol water mixed liquor at 517nm;Measuring 2.0mL molar concentration again is 1.0 × 104Mol/L's Light absorption value A1 of the ethanol water mixed liquor that DPPH solution and 2.0mL volume fraction are 95% at 517nm, by following equation Calculate inhibiting rate: clearance rate (%)={ 1- (A-Ao)/A1 } × 100.Test result is shown in Table 2.
Table 3:DPPH elimination effect test result table
Clearance rate (%)
Embodiment 4 54.3
Embodiment 5 56.9
Embodiment 6 61.4
Activating microcirculation and removing stasis medicinal plaster of the invention, effective component can be rapidly permeated into and is absorbed by the skin, and realize that activating microcirculation and removing stasis medicinal, detumescence stop The effect of pain;Meanwhile improve skin environment, dredge pore, improve skin barrier function, repair impaired skin, have it is anti-oxidant, The effect of removing free radical.
Skin sensibiligen test:
By 20 Kunming small white mouses, SPF grades, 150 ± 10g of weight, half male and half female pushes away tested small white mouse electricity consumption before administration Cutting along vertebra two sides removal gross area is 3 × 3cm, and whether the epilating area for observing small white mouse afterwards for 24 hours is damaged because of depilation, If skin injury, the experiment of intact skin group cannot function as;
By 20 small white mouses with 800# fine sandpaper by epilating area skin tears, not hurt corium, slight oozing of blood is standard, Blank control group 10, administration group 10;
Activating microcirculation and removing stasis medicinal plaster prepared by the embodiment 6 of 2g removes plaster after coating 24 hours, is 0.9% with concentration Sodium chloride solution cleans medicine-feeding part, when then continuing to raise according to conventinal breeding method, while recording toxicity appearing and subsiding Between, removing is first point of observation by the 1h of drug, and later in 8h, for 24 hours, 48h is observed and recorded respectively, if malicious after 48h Property occur, then continue to observe and record.Pay attention to the red and swollen degree in the coating region of small white mouse, hair color, weight, the change of eyes and mucous membrane Change, the behavior expressions such as four limbs activity;
By observation, the basic indifference of skin gloss and control group in coating region, small white mouse activity freely, eyes and viscous Film is without exception, and changes of weight keeps in the reasonable scope, without mice dying, illustrating that liquid adhesive bandage of the invention does not have skin Skin acute toxic reaction.
The preferred embodiment of the present invention has been described in detail above.It should be appreciated that those skilled in the art without It needs creative work according to the present invention can conceive and makes many modifications and variations.Therefore, all technologies in the art Personnel are available by logical analysis, reasoning, or a limited experiment on the basis of existing technology under this invention's idea Technical solution, all should be within the scope of protection determined by the claims.

Claims (8)

1. a kind of activating microcirculation and removing stasis medicinal plaster, which is characterized in that be prepared including following raw materials: Radix Notoginseng, rhizome of chuanxiong, safflower, Radix Salviae Miltiorrhizae, cream Perfume, Radix Angelicae Sinensis, motherwort, Pollen Typhae, borneol, gypsum.
2. a kind of activating microcirculation and removing stasis medicinal plaster, which is characterized in that the raw material including following weight parts is prepared: 50~75 portions of Radix Notoginseng, 25~38 parts of rhizome of chuanxiongs, 15~25 parts of safflowers, 10~30 parts of Radix Salviae Miltiorrhizaes, 10~30 parts of olibanums, 10~20 parts of Radix Angelicae Sinensis, 8~16 parts of benefits are female Grass, 6~20 parts of Pollen Typhaes, 4~8 parts of borneols, 140~270 parts of gypsum.
3. a kind of activating microcirculation and removing stasis medicinal plaster, which is characterized in that the raw material including following weight parts is prepared: 50~75 portions of Radix Notoginseng, 25~38 parts of rhizome of chuanxiongs, 15~25 parts of safflowers, 10~30 parts of Radix Salviae Miltiorrhizaes, 10~30 parts of olibanums, 10~20 parts of Radix Angelicae Sinensis, 8~16 parts of benefits are female Grass, 6~20 parts of Pollen Typhaes, 4~8 parts of borneols, 5-10 portions of litsea citrate oils, 5-10 parts of Fructus Forsythiae oils, 5-10 parts of Rhizoma Acori Graminei oils, 140~ 270 parts of gypsum.
4. a kind of activating microcirculation and removing stasis medicinal plaster, which is characterized in that the raw material including following weight parts is prepared: 50~75 portions of Radix Notoginseng, 25~38 parts of rhizome of chuanxiongs, 15~25 parts of safflowers, 10~30 parts of Radix Salviae Miltiorrhizaes, 10~30 parts of olibanums, 10~20 parts of Radix Angelicae Sinensis, 8~16 parts of benefits are female Grass, 6~20 parts of Pollen Typhaes, 4~8 parts of borneols, 5-10 portions of litsea citrate oils, 5-10 parts of Fructus Forsythiae oils, 5-10 parts of Rhizoma Acori Graminei oils, 2-8 parts Pollen extract, 140~270 parts of gypsum.
5. a kind of activating microcirculation and removing stasis medicinal plaster, which is characterized in that the raw material including following weight parts is prepared: 50~75 portions of Radix Notoginseng, 25~38 parts of rhizome of chuanxiongs, 15~25 parts of safflowers, 10~30 parts of Radix Salviae Miltiorrhizaes, 10~30 parts of olibanums, 10~20 parts of Radix Angelicae Sinensis, 8~16 parts of benefits are female Grass, 6~20 parts of Pollen Typhaes, 4~8 parts of borneols, 5-10 portions of litsea citrate oils, 5-10 parts of Fructus Forsythiae oils, 5-10 parts of Rhizoma Acori Graminei oils, 2-8 parts Pollen extract, 0.2-3 part Sodium Aescinate and/or albiflorin, 140~270 parts of gypsum.
6. a kind of activating microcirculation and removing stasis medicinal plaster, which is characterized in that the raw material including following weight parts is prepared: 50~75 portions of Radix Notoginseng, 25~38 parts of rhizome of chuanxiongs, 15~25 parts of safflowers, 10~30 parts of Radix Salviae Miltiorrhizaes, 10~30 parts of olibanums, 10~20 parts of Radix Angelicae Sinensis, 8~16 parts of benefits are female Grass, 6~20 parts of Pollen Typhaes, 4~8 parts of borneols, 5-10 portions of litsea citrate oils, 5-10 parts of Fructus Forsythiae oils, 5-10 parts of Rhizoma Acori Graminei oils, 2-8 parts The mixture of pollen extract, 0.2-3 part Sodium Aescinate and albiflorin, 140~270 parts of gypsum;The otoginsenoside The mass ratio of sodium and albiflorin is (1-3): (1-3).
7. such as the described in any item activating microcirculation and removing stasis medicinal plaster of claim 4~6, which is characterized in that the preparation of the pollen extract Method is as follows: 5-8g pollen is carried out supercritical carbon dioxide extracting, extracting pressure 25-35MPa, extraction temperature 45-55 DEG C, extraction time is 2-4 hours, carbon dioxide flow rate 40-50L/h, and I temperature of separating still is 40-50 DEG C, pressure 10- 15MPa, II temperature of separating still are 25-35 DEG C, pressure 5-8MPa, collect supercritical extract to get pollen extract is arrived.
8. the preparation method of activating microcirculation and removing stasis medicinal plaster as described in any one of claims 1 to 7, which is characterized in that including following step It is rapid:
S1 weighs raw material by weight, and Radix Notoginseng, rhizome of chuanxiong, safflower, Radix Salviae Miltiorrhizae, olibanum, Radix Angelicae Sinensis, motherwort, Pollen Typhae are crushed to 80 ~300 mesh obtain Chinese medicine coarse powder, are 60~80% by the mass fraction that Chinese medicine coarse powder is added to 5~10 times of Chinese medicine coarse powder weight In ethanol water, 1.5~4h of extraction is stirred at reflux at 70~85 DEG C, filter, be evaporated under reduced pressure to relative density be 1.15~ 1.22, obtain paste extract;
S2 is by paste extract, borneol, litsea citrate oil (if there is), Fructus Forsythiae oil (if there is), Rhizoma Acori Graminei oil (if there is), pollen Extract (if there is), Sodium Aescinate (if there is), albiflorin (if there is), gypsum are uniformly mixed, and are lived Blood stasis-resolving plaster.
CN201811010186.3A 2018-08-31 2018-08-31 A kind of activating microcirculation and removing stasis medicinal plaster Withdrawn CN108938858A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811010186.3A CN108938858A (en) 2018-08-31 2018-08-31 A kind of activating microcirculation and removing stasis medicinal plaster

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811010186.3A CN108938858A (en) 2018-08-31 2018-08-31 A kind of activating microcirculation and removing stasis medicinal plaster

Publications (1)

Publication Number Publication Date
CN108938858A true CN108938858A (en) 2018-12-07

Family

ID=64475115

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811010186.3A Withdrawn CN108938858A (en) 2018-08-31 2018-08-31 A kind of activating microcirculation and removing stasis medicinal plaster

Country Status (1)

Country Link
CN (1) CN108938858A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109966465A (en) * 2019-04-23 2019-07-05 杨峰 A kind of drug and preparation method thereof for treating cervical vertebra

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103142938A (en) * 2013-03-27 2013-06-12 赵振德 Plaster for treating traumatic injury and fracture
CN103494972A (en) * 2013-10-11 2014-01-08 鞠德奎 Unguent for treating rheumatic bone pain
CN106074952A (en) * 2016-08-17 2016-11-09 赵昕秋 A kind of motion strain plaster

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103142938A (en) * 2013-03-27 2013-06-12 赵振德 Plaster for treating traumatic injury and fracture
CN103494972A (en) * 2013-10-11 2014-01-08 鞠德奎 Unguent for treating rheumatic bone pain
CN106074952A (en) * 2016-08-17 2016-11-09 赵昕秋 A kind of motion strain plaster

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
康健等: ""7651"膏药消炎止痛效果临床观察 ", 《西北国防医学杂志》 *
田燕: "《中药学专业知识 1》", 30 November 2016, 中国中医药出版社 *
陈士林: "《中华医学百科全书 中药资源学》", 30 April 2018, 中国协和医科大学出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109966465A (en) * 2019-04-23 2019-07-05 杨峰 A kind of drug and preparation method thereof for treating cervical vertebra

Similar Documents

Publication Publication Date Title
US6027728A (en) Herbal skin regeneration composition and method
CN102145077B (en) Oral Chinese medical preparation for treating acute periodontitis
CN103041173A (en) Traditional Chinese medicine external preparation for curing dermatitis and eczema and preparing method thereof
CN101518600B (en) Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof
CN104383134A (en) Traditional Chinese medicine preparation for treating phlebotomized wound infection and production method of traditional Chinese medicine preparation
CN100344303C (en) Wet pad for treating piles
CN103239662A (en) Parasite expelling Chinese herbal preparation for animals
CN108938858A (en) A kind of activating microcirculation and removing stasis medicinal plaster
CN101336993B (en) External tincture for treating wind-dampness arthralgia and urgent sprain and preparation method thereof
CN104398997B (en) It is a kind of for Chinese medicine composition of scleroderma circumscriptum and preparation method thereof
CN114010571B (en) Natural extract for soothing skin and improving skin quality and application thereof
CN105213584A (en) A kind of Chinese medicine composition for the treatment of eczema and preparation method thereof
CN111840416A (en) Marrow-washing bone-setting liquid
CN104940886A (en) External preparation for treating seborrheic alopecia and preparing method thereof
CN102579868B (en) Method for preparing traditional Chinese medicine lotion for treating ecthyma caused by conversion of liver depression into fire
CN113599480A (en) Scraping oil for relieving hyperplasia of mammary glands symptoms and preparation method thereof
CN103341044B (en) Itching-relieving compound preparation and preparation method thereof
CN105687432A (en) Application of traditional Chinese medicine composition in preparation of medicines for treating eczema
CN105663937A (en) Traditional Chinese medicine preparation for treating breast eczema and preparation method thereof
CN106692458A (en) Medicine composition for treating acnes as well as preparation method and application thereof
CN104666799A (en) Blood circulation activating and blood stasis removing medicinal liquor for soft tissue injury and preparation method of medicinal liqour
CN109939209A (en) A kind of quickly logical nose emulsifiable paste
CN105232886B (en) Three imperial medicated wines and preparation method
CN104383376A (en) Traditional Chinese medicinal composition for treating woman vulva squamous epithelial cell proliferation
CN103948684A (en) Externally-applied liniment for treating leucoderma

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20181207